RLSC.CN - RISE Life Science Corp.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
0.15
-0.01 (-6.25%)
At close: 3:42PM EDT
Stock chart is not supported by your current browser
Previous Close0.16
Open0.15
Bid0.15 x 0
Ask0.17 x 0
Day's Range0.15 - 0.15
52 Week Range0.05 - 0.74
Volume2,000
Avg. Volume37,726
Market Cap8.872M
Beta (3Y Monthly)3.11
PE Ratio (TTM)N/A
EPS (TTM)-0.10
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile18 days ago

    Scott Secord Joins RISE Board of Directors as Executive Chairman

    Toronto, Ontario--(Newsfile Corp. - October 3, 2018) -  RISE Life Science Corp. (CSE: RLSC) (the "Company and/or "RISE") today announced that Scott Secord, formerly Chief Executive Officer of Gaming Nation, has been appointed to RISE's board of directors and the position of Executive Chairman.Mr. Secord served as Chief Executive Officer of Gaming Nation from June 2015 until its recent purchase by a U.S. based private equity group. Gaming Nation, formerly listed on the ...

  • GlobeNewswirelast month

    California’s Crucial Role in the Cannabis Retail Market -- CFN Media

    CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing RISE Life Science Corp.’s (RLSC.CN) California-based retail strategy. While there are many public companies with plans to establish operations in California, there are not too many with an established roster of products and distribution networks. Headquartered in Toronto, and listed in Canada, RISE Life Science is firmly focused on developing a strong consumer products presence in California before spreading out across North America.

  • Newsfile2 months ago

    RISE Enters Commercialization Phase with Retail Sales in California

    Growing retail revenue and momentum in the largest consumer cannabis market in the world Toronto, Ontario--(Newsfile Corp. - August 20, 2018) - RISE Life Science Corp. (CSE: RLSC) (the "Company and/or "RISE") is poised for commercial success and leading the way among product and branding companies entering California, the largest cannabis market in the world, according to Bloomberg and other sources."We positioned our company for the future of this industry," commented Anton Mattadeen, CEO ...

  • Newsfile3 months ago

    RISE Welcomes Ryan Rocca as New Board Member

    Toronto, Ontario--(Newsfile Corp. - August 3, 2018) - RISE Life Science Corp. (the "Company and/or "RISE") (CSE:RLSC) welcomes Ryan Rocca to its board of directors. Rocca is also named the General Manager of RISE Life Science Corp. USA and has also served as the President and Chief Executive Officer of the Cultivate Kind and Modern Marketing sister agencies, as well as Managing Partner of Life Bloom Organics.Rocca has a passion for bringing emerging brands ...

  • GlobeNewswire3 months ago

    RISE Expands Product Portfolio & Strengthens Organization with Acquisition -- CFN Media

    CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering RISE Life Science Corp.'s (CSE:RLSC) recent acquisitions of two California-based companies to expand its product portfolio, intellectual property, and distribution channels. The U.S. cannabis industry is expected to reach more than $75 billion in size by 2030, according to Cowen & Co., driven by the legalization of medical and adult-use cannabis across a growing number of states. Not surprisingly, these rapid growth rates have spurred a lot of strategic acquisitions as cannabis brands look to establish dominance.

  • Newsfile3 months ago

    RISE Closes Deal to Buy Cultivate Kind and Life Bloom Organics

    Precedent-setting acquisition immediately expands the RISE product portfolio and deepens the company's vertical integration as it rolls out cannabis-based health and wellness products in the California market Toronto, Ontario--(Newsfile Corp. - July 12, 2018) - RISE Life Science Corp. (CSE: RLSC) (the "Company and/or "RISE") has completed the previously announced acquisition of 100% interest in California-based Cultivate Kind and Life Bloom Organics.The acquisition of Life Bloom Organics will immediately expand RISE's portfolio of CBD products ...

  • Newsfile4 months ago

    RISE Life Science Corp. Announces Closing $1.4M of Equity Financing

    — Canadian Health and Wellness Product Pioneer Poised for Growth and Expansion — Toronto, Ontario--(Newsfile Corp. - July 3, 2018) - RISE Life Science Corp. (CSE: RLSC) (the "Company" or "RISE") today announces that it has closed a non-brokered private placement (the "Offering") through the issuance of an aggregate of 4,824,399 units (each a "Unit") at a price of $0.30 per Unit for gross proceeds of $1,447,319.70. Each Unit is comprised of one common ...

  • Newsfile4 months ago

    RISE Life Science Corp. Announces U.S. Retail Debut of Karezza, New CBD Brand

    Canadian Health and Wellness Product Pioneer brings first products to market Toronto, Ontario--(Newsfile Corp. - June 21, 2018) - RISE Life Science Corp. (CSE: RLSC) (the "Company" and/or "RISE") today announced the launch of its CBD-based wellness brand, Karezza, at retail in California as of June 20, 2018.Karezza is a suite of sexual wellness supplements that today includes a couples "In the Moment" mood support supplement, plus a "Women's Daily" supplement and a "Men's Daily" ...

  • Newsfile4 months ago

    RISE Life Science Provides Operational Update

    Toronto, Ontario--(Newsfile Corp. - June 8, 2018) - RISE Life Science Corp. (CSE: RLSC) (the "Company" and/or "RISE"), today provided an operational update on its plans and projected timelines for the 2018 calendar year. RISE is pleased to announce that it expects to launch its own commercial products for sale in the California market on or about its previously announced launch date of 6/20/2018."With the recent introduction of the RISE Report on SEX ...

  • Newsfile4 months ago

    RISE Life Science Corp. to Acquire California CDB Company Life Bloom Organics and Leading Cannabis Brand Strategy Agency Cultivate Kind

    Toronto, Ontario--(Newsfile Corp. - June 7, 2018) - RISE Life Science Corp. (CSE: RLSC) (the "Company" and/or "RISE")  is pleased to announce that it has signed a Letter of Intent (LOI) to acquire 100% of Life Bloom Organics, LLC, a California company that produces and markets organic oral sprays containing CBD, and 100% of Cultivate Kind, one of the top marketing and branding agencies for the cannabis industry in the United States."This represents a ...

  • Newsfile6 months ago

    RISE Life Science Corp. Announces the RISE Report: A Study to Explore Cannabis Use and Sexual Health

    Study to reveal the health benefits of cannabis products and their relation to sexual health Toronto, Ontario--(Newsfile Corp. - April 24, 2018) - RISE Life Science Corp. (CSE: RLSC) (formerly Luminor Medical Technologies Inc.) (the "Company" and/or "RISE") today announced that it has commissioned a longitudinal study to investigate sexual function and health concerns, and, how cannabis products designed for sexual enhancement and health affect sexual behaviors and performance. The RISE Report on Cannabis ...

  • Newsfile6 months ago

    RISE Life Science Corp. Announces Closing $2.2M of Equity Financing

    Toronto, Ontario--(Newsfile Corp. - April 19, 2018) - RISE Life Science Corp. (CSE: RLSC) (formerly Luminor Medical Technologies Inc. (the "Company" or "RISE") is pleased to announce that, further to it press release dated March 29, 2018, it has closed tranches (each a "Tranche") of its previously announced non-brokered private placement (the "Offering") through the issuance of an aggregate of 7,366,166 units (each a "Unit") at a price of $0.30 per Unit for gross ...

  • Newsfile7 months ago

    RISE Life Science Announces Private Placement of Units

    Toronto, Ontario--(Newsfile Corp. - March 29, 2018) - RISE Life Science Corp. (CSE: RLSC) (formerly Luminor Medical Technologies Inc.) (the "Company") announces that it intends to complete a non-brokered private placement of up to 10,000,000 units ("Units") at a price of $0.30 per Unit (the "Issue Price") for gross proceeds of up to $3,000,000 (the "Offering"). Each Unit will be comprised of one common share ("Common Share") of the Company and one-half of ...